• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$3.77 -$0.10 (-2.58%)

REAL-TIME: Last trade at

Pain Therapeutics, Inc.

NASDAQ:PTIE

Jump to this page for:

Related Resources

Pain Therapeutics Inc. (PTIE) Beats Q1 Profit Views by 1c/Share

5/8/2012 by StreetInsider.com

Pain Therapeutics reports Q1 EPS 0c, consensus (1c)

5/8/2012 by Theflyonthewall.com

Pain Therapeutics issued four U.S. Patents for REMOXY

5/3/2012 by Theflyonthewall.com

Biotechnology Value Fund reports 5.7% passive stake in Pain Therapeutics

4/23/2012 by Theflyonthewall.com

Pain Therapeutics Inc. (PTIE) Misses Q4 EPS by 4c

2/9/2012 by StreetInsider.com

Pain Therapeutics reports Q4 EPS (1c) vs. consensus (2c)

2/9/2012 by Theflyonthewall.com

Pain Therapeutics Reports 2011 Financial Results

2/9/2012 by GlobeNewswire

Harwood Feffer LLP Announces Investigation of Pain Therapeutics, Inc.

1/6/2012 by StockWatch

Harwood Feffer LLP Announces Investigation of Pain Therapeutics, Inc.

1/6/2012 by Business Wire

The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Pain Therapeutics, Inc. of Class Action Lawsuit and the Deadline of January 31, 2012 to Seek a Lead Plaintiff Position

1/5/2012 by StockWatch

The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Pain Therapeutics, Inc. of Class Action Lawsuit and the Deadline of January 31, 2012 to Seek a Lead Plaintiff Position

1/5/2012 by Business Wire

Robbins Umeda LLP Announces an Investigation of Pain Therapeutics, Inc.

12/12/2011 by Business Wire

Brower Piven Encourages Investors Who Have Losses in Excess of $200,000 From Investment in Pain Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the January 31, 2012 Lead Plaintiff Deadline

12/10/2011 by StockWatch

Brower Piven Encourages Investors Who Have Losses in Excess of $200,000 From Investment in Pain Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the January 31, 2012 Lead Plaintiff Deadline

12/10/2011 by Marketwire

Faruqi & Faruqi, LLP Announces Investigation of Pain Therapeutics, Inc.

12/5/2011 by StockWatch

Faruqi & Faruqi, LLP Announces Investigation of Pain Therapeutics, Inc.

12/5/2011 by Business Wire

The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Pain Therapeutics, Inc. of Class Action Lawsuit and the Deadline of January 31, 2012 to Seek a Lead Plaintiff Position

12/5/2011 by StockWatch

The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Pain Therapeutics, Inc. of Class Action Lawsuit and the Deadline of January 31, 2012 to Seek a Lead Plaintiff Position

12/5/2011 by Marketwire

Pain Therapeutics reports Q3 EPS (2c) vs. consensus (2c)

11/3/2011 by Theflyonthewall.com

Pain Therapeutics Reports Q3 2011 Financial Results

11/3/2011 by GlobeNewswire

Pain Therapeutics (PTIE) COO Nadav Friedmann sells 25,000 Shares

10/24/2011 by GuruFocus

Wall Street's Wrong About These Stocks

10/10/2011 by The Motley Fool

Pain Therapeutics (PTIE) COO Nadav Friedmann sells 25,000 Shares

10/4/2011 by GuruFocus

3 Stocks Stopping the Presses

9/19/2011 by The Motley Fool

A Less Painful FDA Decision

8/29/2011 by The Motley Fool

Bronstein, Gewirtz & Grossman, LLC Investigates Miller Energy Resources, Inc.

8/26/2011 by Business Wire

Pain Therapeutics says REMOXY can generate meaningful revenue

8/4/2011 by Theflyonthewall.com

Pain Therapeutics reports Q2 EPS (3c) vs. consensus (2c)

8/4/2011 by Theflyonthewall.com

Pain Therapeutics Reports Q2 2011 Financial Results

8/4/2011 by GlobeNewswire

Like It (Almost) Never Happened

7/26/2011 by The Motley Fool

Research Report on Pain Therapeutics, Inc. and Cephalon, Inc. -- Companies Help You Feel Better

7/7/2011 by Marketwire

3 Top Stocks at Half-Price

7/5/2011 by The Motley Fool

5 of Last Week's Biggest Losers

7/5/2011 by The Motley Fool

Pain Therapeutics risk/reward attractive, says Gabelli

6/30/2011 by Theflyonthewall.com

Pain Therapeutics and Neoprobe Present Promising Pipelines

6/30/2011 by Marketwire

Why Did My Stock Just Die?

6/28/2011 by The Motley Fool

Equity Research on Pain Therapeutics, Inc. and Durect Corporation - No Pain, No Gain

6/28/2011 by Marketwire

FDA Complete Response Letter Received For REMOXY

6/28/2011 by Medical News Today - UK

With the Market Choppiness, Ease Into Stocks Slowly (PKE, TTWO, VIT, PTIE, XCO)

6/27/2011 by tickerspy.com

Double Ouch! 2 Monster Drops in 2 Trading Days

6/27/2011 by The Motley Fool
See More Articles...